UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition

Nature communications, 2021-05, Vol.12 (1), p.2498-2498, Article 2498

2021

Link zum Volltext

Verfügbarkeit prüfen

Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells

Clinical cancer research, 2017-05, Vol.23 (9), p.2277-2288

2017

Link zum Volltext

Verfügbarkeit prüfen

Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary

EMBO molecular medicine, 2023-03, Vol.15 (3), p.e16104-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Expression and Functional Regulation of Myoglobin in Epithelial Cancers

The American journal of pathology, 2009-07, Vol.175 (1), p.201-206

2009

Link zum Volltext

Verfügbarkeit prüfen

Cytokine-Induced Killer Cells Eradicate Bone and Soft-Tissue Sarcomas

Cancer research (Chicago, Ill.), 2014, Vol.74 (1), p.119-129

2014

Link zum Volltext

Verfügbarkeit prüfen

Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report

EMBO molecular medicine, 2020-07, Vol.12 (7), p.e11756-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma

Journal of experimental & clinical cancer research, 2023-11, Vol.42 (1), p.1-310, Article 310

2023

Link zum Volltext

Verfügbarkeit prüfen

Ab-Induced Ectodomain Shedding Mediates Hepatocyte Growth Factor Receptor down-Regulation and Hampers Biological Activity

Proceedings of the National Academy of Sciences - PNAS, 2006-03, Vol.103 (13), p.5090-5095

2006

Link zum Volltext

Verfügbarkeit prüfen

Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy

Oncoimmunology, 2018-11, Vol.7 (11), p.e1465161-e1465161

2018

Link zum Volltext

Verfügbarkeit prüfen

Improved Outcome Prediction for Appendiceal Pseudomyxoma Peritonei by Integration of Cancer Cell and Stromal Transcriptional Profiles

Cancers, 2020-06, Vol.12 (6), p.1495

2020

Link zum Volltext

Verfügbarkeit prüfen

Genetic targeting of the kinase activity of the Met receptor in cancer cells

Proceedings of the National Academy of Sciences - PNAS, 2007-07, Vol.104 (27), p.11412-11417

2007

Link zum Volltext

Verfügbarkeit prüfen

Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)

Virchows Archiv : an international journal of pathology, 2023-03, Vol.482 (3), p.463-475

2023

Link zum Volltext

Verfügbarkeit prüfen

CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes

Clinical cancer research, 2020-12, Vol.26 (23), p.6321-6334

2020

Link zum Volltext

Verfügbarkeit prüfen

A pancreatic metastasis from a colon carcinoma mimicking a primary tumor diagnosed by EUS-guided fine-needle biopsy

Endoscopic Ultrasound, 2023-01, Vol.12 (1), p.162-163

2023

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)

Virchows Archiv : an international journal of pathology, 2023-03, Vol.482 (3), p.477-477

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2871: Hypermetastatic stem-like cells from 'cancer of unknown primary' (CUP) model multi-organ dissemination and unveil liability to MEK inhibition

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2871-2871

2021

Link zum Volltext

Verfügbarkeit prüfen

HIV Protease Inhibitors Block HPV16-Induced Murine Cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction

Molecular cancer therapeutics, 2020-12, Vol.19 (12), p.2476-2489

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of upfront multidisciplinary tumor board (MTB) evaluation on breast sarcoma (BS) outcome

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e23546-e23546

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract 569: Expression and modulation by IFN of HLA class I APM components in melanoma: Potential biomarkers of clinical response to checkpoint inhibitors

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.569-569

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2290: Effective immunotherapy with cytokine-induced killer cells against autologous melanoma cancer stem cells

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2290-2290

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2812: CSPG4-specific CAR.CIK lymphocyte-based immunotherapy to eliminate HLA class I-defective melanoma tumors

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2812-2812

2022

Link zum Volltext

Verfügbarkeit prüfen

In melanocytic lesions the fraction of BRAFV600E alleles is associated with sun exposure but unrelated to ERK phosphorylation

Modern pathology, 2008-06, Vol.21 (6), p.716-726

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

KollektionWiley Online Library Full Collection 2018

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(30)

Publikationsform

Sprache

Englisch
(31)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition

Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells

Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary

Expression and Functional Regulation of Myoglobin in Epithelial Cancers

Cytokine-Induced Killer Cells Eradicate Bone and Soft-Tissue Sarcomas

Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report

CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma

Ab-Induced Ectodomain Shedding Mediates Hepatocyte Growth Factor Receptor down-Regulation and Hampers Biological Activity

PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas-A Preclinical and Translational Study

Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy

Improved Outcome Prediction for Appendiceal Pseudomyxoma Peritonei by Integration of Cancer Cell and Stromal Transcriptional Profiles

Genetic targeting of the kinase activity of the Met receptor in cancer cells

Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group

Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)

Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization

CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes

A pancreatic metastasis from a colon carcinoma mimicking a primary tumor diagnosed by EUS-guided fine-needle biopsy

Correction to: Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)

Abstract 2871: Hypermetastatic stem-like cells from 'cancer of unknown primary' (CUP) model multi-organ dissemination and unveil liability to MEK inhibition

HIV Protease Inhibitors Block HPV16-Induced Murine Cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction

Impact of upfront multidisciplinary tumor board (MTB) evaluation on breast sarcoma (BS) outcome

Abstract 569: Expression and modulation by IFN of HLA class I APM components in melanoma: Potential biomarkers of clinical response to checkpoint inhibitors

Abstract 2290: Effective immunotherapy with cytokine-induced killer cells against autologous melanoma cancer stem cells

Abstract 2812: CSPG4-specific CAR.CIK lymphocyte-based immunotherapy to eliminate HLA class I-defective melanoma tumors

In melanocytic lesions the fraction of BRAFV600E alleles is associated with sun exposure but unrelated to ERK phosphorylation

Aktive Filter

Suchergebnisse filtern